IF can improve the loss of AQP4 polarity in the cerebral cortex of AD model rats by reducing the AQP4-M 1/M23 and increasing the SNTA1 expression levels, thus effectively preventing AD [59]. The gene discussed is AQP4; the disease is Alzheimer disease.